Trial Profile
Prospective observational study to investigate the risk of residual neuromuscular block (RNMB) induced by rocuronium in type 2 diabetes mellitus patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Neuromuscular blockade
- Focus Adverse reactions; Pharmacodynamics
- 26 Nov 2015 New trial record